Shamrock Medicaments (India) Limited, a active public limited company, was established on 30 August 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51397MH2001PLC133209. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Formerly known as Shamrock Medicaments(India) Limited, Shamrock Remedies(India) Limited. It upholds a compliant status. Its leadership includes Jitesh Khokhani Rameshchandra (Director), Sangini K Khokhani (Director), Kalpesh Rameshchandra Khokhani (Director). Past directors included Shakuntala Harnam Israni. It holds ₹2.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 83 E, Hansraj Pragji Building,Off Dr. E Moses Road Dr. E Moses Road, Worli, Mumbai, Maharashtra, 400018.
U51397MH2001PLC133209
133209
30 August 2001
₹1.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shamrock Medicaments (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitesh Khokhani Rameshchandra | Director | 01 Dec 2006 | Current |
| Sangini K Khokhani | Director | 01 Dec 2006 | Current |
| Kalpesh Rameshchandra Khokhani | Director | 30 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shamrock Medicaments (India) Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.89% increase. The company also saw a substantial improvement in profitability, with a 181.86% increase in profit. The company's net worth Soared by an impressive increase of 34.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shamrock Medicaments (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2021 | Hdfc Bank Limited | ₹2.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shamrock Medicaments (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shamrock Medicaments (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shamrock Medicaments (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shamrock Medicaments (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Shamrock Medicaments (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 2.60 M with Charge ID 100494553 was registered on 06 Oct 2021. was recorded as a recent event.
Kalpesh Rameshchandra Khokhani was appointed as a Director was appointed as a Director on 30 Aug 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
Progress on Jitesh Khokhani Rameshchandra was appointed as a Director was appointed as a Director on 01 Dec 2006 & has been associated with this company since 19 years 1 day . was documented.
Progress on Sangini K Khokhani was appointed as a Director was appointed as a Director on 01 Dec 2006 & has been associated with this company since 19 years 1 day . was documented.
The CIN of Shamrock Medicaments (India) Limited is U51397MH2001PLC133209.
Shamrock Medicaments (India) Limited is headquartered at 83 E, Hansraj Pragji Building,Off Dr. E Moses Road Dr. E Moses Road, Worli, Mumbai, Maharashtra, 400018.
Shamrock Medicaments (India) Limited was incorporated on 30 August 2001.
The current directors of Shamrock Medicaments (India) Limited are
The primary industry of Shamrock Medicaments (India) Limited is Trade.
Shamrock Medicaments (India) Limited is unlisted.
The authorized capital of Shamrock Medicaments (India) Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Shamrock Medicaments (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX